Author
Listed:
- Marcel Naumann
(Technische Universität Dresden)
- Arun Pal
(Technische Universität Dresden)
- Anand Goswami
(RWTH Aachen University Hospital)
- Xenia Lojewski
(Technische Universität Dresden)
- Julia Japtok
(Technische Universität Dresden)
- Anne Vehlow
(Helmholtz-Zentrum Dresden-Rossendorf
partner site Dresden, and German Cancer Research Center (DKFZ)
Institute of Radiooncology—OncoRay)
- Maximilian Naujock
(Hannover Medical School
Boehringer Ingelheim Pharma GmbH & Co. KG)
- René Günther
(Technische Universität Dresden)
- Mengmeng Jin
(Technische Universität Dresden)
- Nancy Stanslowsky
(Hannover Medical School)
- Peter Reinhardt
(Technische Universität Dresden
AbbVie Deutschland GmbH & Co. KG)
- Jared Sterneckert
(Technische Universität Dresden)
- Marie Frickenhaus
(Max Planck Institute for Molecular Biomedicine
University of Münster)
- Francisco Pan-Montojo
(Klinikum der Universität München, and Munich Cluster for Systems Neurology)
- Erik Storkebaum
(Max Planck Institute for Molecular Biomedicine
University of Münster
Department of Molecular Neurobiology, Donders Institute for Brain, Cognition and Behaviour, Radboud University)
- Ina Poser
(Max Planck Institute of Molecular Cell Biology and Genetics)
- Axel Freischmidt
(University Ulm)
- Jochen H. Weishaupt
(University Ulm)
- Karlheinz Holzmann
(Centre for Biomedical Research)
- Dirk Troost
(Academic Medical Centre)
- Albert C. Ludolph
(University Ulm)
- Tobias M. Boeckers
(University of Ulm)
- Stefan Liebau
(Eberhard Karls University of Tübingen)
- Susanne Petri
(Hannover Medical School)
- Nils Cordes
(Helmholtz-Zentrum Dresden-Rossendorf
partner site Dresden, and German Cancer Research Center (DKFZ)
Institute of Radiooncology—OncoRay
Technische Universität Dresden)
- Anthony A. Hyman
(Max Planck Institute of Molecular Cell Biology and Genetics)
- Florian Wegner
(Hannover Medical School)
- Stephan W. Grill
(Max Planck Institute of Molecular Cell Biology and Genetics
Technische Universität Dresden)
- Joachim Weis
(RWTH Aachen University Hospital)
- Alexander Storch
(Technische Universität Dresden
Technische Universität Dresden
German Center for Neurodegenerative Diseases (DZNE), Research Site Rostock
University of Rostock)
- Andreas Hermann
(Technische Universität Dresden
Technische Universität Dresden
German Center for Neurodegenerative Diseases (DZNE), Research Site Rostock)
Abstract
Amyotrophic lateral sclerosis (ALS) is the most frequent motor neuron disease. Cytoplasmic fused in sarcoma (FUS) aggregates are pathological hallmarks of FUS-ALS. Proper shuttling between the nucleus and cytoplasm is essential for physiological cell function. However, the initial event in the pathophysiology of FUS-ALS remains enigmatic. Using human induced pluripotent stem cell (hiPSCs)-derived motor neurons (MNs), we show that impairment of poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response (DDR) signaling due to mutations in the FUS nuclear localization sequence (NLS) induces additional cytoplasmic FUS mislocalization which in turn results in neurodegeneration and FUS aggregate formation. Our work suggests that a key pathophysiologic event in ALS is upstream of aggregate formation. Targeting DDR signaling could lead to novel therapeutic routes for ameliorating ALS.
Suggested Citation
Marcel Naumann & Arun Pal & Anand Goswami & Xenia Lojewski & Julia Japtok & Anne Vehlow & Maximilian Naujock & René Günther & Mengmeng Jin & Nancy Stanslowsky & Peter Reinhardt & Jared Sterneckert & M, 2018.
"Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation,"
Nature Communications, Nature, vol. 9(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-017-02299-1
DOI: 10.1038/s41467-017-02299-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-017-02299-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.